Variable | Total n = 17 |
---|---|
Age, M (range) | 47 (20–87) |
Sex | |
Female, N (%) | 11 (65%) |
Educational level | |
Primary school | 1 (6%) |
Secondary school | 12 (71%) |
University | 4 (24%) |
Occupation | |
Employed/student | 12 (71%) |
Unemployed | 3 (18%) |
Retired | 3 (18%) |
Sick leave (n = 15)a | |
100% | 2 (12%) |
75% | 2 (12%) |
50% | 2 (12%) |
25% | 3 (18%) |
Not on sick leave | 8 (47%) |
Psychiatric diagnosis currently treated at the unit | |
PTSD | 5 (29%) |
Depression or dystyhimia | 4 (24%) |
Bipolar disorder 2 | 3 (18%) |
Bipolar disorder 1 | 2 (12%) |
Anxiety disorder | 2 (12%) |
Other | 1 (6%) |
Comorbid psychiatric disordersb | |
Alcohol and/or substance abuse/addiction | 4 (24%) |
ADHD | 3 (18%) |
Depression | 2 (12%) |
Anxiety disorders | 1 (6%) |
Other | 1 (6%) |
Duration of sleep problems | |
Mean years (range) | 3 (0.4–10 years) |
0,4-0,9 | 3 (18%) |
1–2 | 8 (47%) |
2,1–5 | 3 (18%) |
5,1–10 | 3 (18%) |
Pre-treatment Insomnia Severity | |
Mean ISI score (SD) | 19.5 (4.7) |
Clinical insomnia, severe (22–28 points) | 5 (29%) |
Clinical insomnia, moderate severity (15–21 points) | 10 (59%) |
Sub-threshold insomnia (8–14 points) | 2 (12%) |
No clinically significant insomnia (0–7) | 0 (0%) |
Sleep medications n (%) | |
None | 1 (6%) |
One type of drug (e.g. antihistamine or z-drug) | 9 (53%) |
Two types of drugs (e.g. antihistamine and z-drug) | 7 (41%) |
Type of sleep medicationc n (%) | |
Antihistamines | 9 (53%) |
Z-drugs | 8 (47%) |
Benzodiazepines | 3 (18%) |
Melatonin | 1 (6%) |
Propiomazin | 1 (6%) |
Duration of sleep medication use n (%) | |
Mean years (range) | 2.9 (0.4–10) |
0,4-0,9 | 2 (12%) |
1–2 | 8 (47%) |
2,1–5 | 3 (18%) |
5,1–10 | 3 (18%) |
Other medications c n (%) | |
Antidepressant (SSRI, SNRI, NaSSA, SNRI, NDRI) | 13 (76%) |
Lithium | 4 (24%) |
Anticonvulsant (e.g. valproat) | 3 (18%) |
Stimulants (e.g. methylfenidate) | 3 (18%) |
Antipsychotics (e.g. qeutiapin) | 3 (18%) |
Opioid substitution drug | 1 (6%) |
Benzodiazepines | 1 (6%) |